MedTrace Logo

Habit Formation for Adherence to Statin Use and LDL Reduction

NCT01798784 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 805

Last updated 2020-05-20

No results posted yet for this study

Summary

In a 4-arm, Randomized Control Trial among members of CVS Caremark or Penn Medicine Patients with suboptimal cholesterol control who are at high risk for CVD, the study investigators propose to test the effectiveness of different behavioral economic techniques in inducing habit formation for adherence to statin use and sustained reductions in LDL cholesterol after financial incentives are discontinued. Primary outcome is changes in LDL from enrollment to 12 months (6 months after cessation of financial incentives).

Conditions

  • Medication Adherence

Interventions

BEHAVIORAL

Sweepstake Incentive 1

Daily sweepstake conditional on daily medication adherence

BEHAVIORAL

Sweepstake Incentive 2

Daily sweepstake conditional on daily medication adherence

BEHAVIORAL

Sweepstake Incentive 3

Daily sweepstake conditional on daily medication adherence

Sponsors & Collaborators

Principal Investigators

  • Kevin Volpp, MD, PhD · University of Pennsylvania

  • Iwan Barankay, PhD · University of Pennsylvania

  • Peter Reese, MD, MSCE · University of Pennsylvania

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-07-31
Primary Completion
2017-09-30
Completion
2017-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01798784 on ClinicalTrials.gov